Invention Grant
- Patent Title: Transgenic mice having a human major histocompatibility complex (MHC) phenotype, experimental uses and applications
-
Application No.: US13551137Application Date: 2012-07-17
-
Publication No.: US09986721B2Publication Date: 2018-06-05
- Inventor: Claude Auriault , Véronique Pancre , Yu-Chun Lone , Anthony Pajot , François Lemonnier
- Applicant: Claude Auriault , Véronique Pancre , Yu-Chun Lone , Anthony Pajot , François Lemonnier
- Applicant Address: FR Paris FR Paris
- Assignee: INSTITUT PASTEUR,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
- Current Assignee: INSTITUT PASTEUR,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
- Current Assignee Address: FR Paris FR Paris
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner L.L.P.
- Main IPC: G01N33/00
- IPC: G01N33/00 ; A01K67/00 ; A01K67/027 ; A61K49/00 ; C07K14/74 ; C12N15/85 ; C12N15/00

Abstract:
The present invention relates to transgenic mice and isolated transgenic mouse cells, the mice and mouse cells comprising a disrupted H2 class I gene, a disrupted H2 class II gene, a functional HLA class I transgene, and a functional HLA class II transgene. In embodiments, the transgenic mouse or mouse cells are deficient for both H2 class I and class II molecules, wherein the transgenic mouse comprises a functional HLA class I transgene and a functional HLA class II transgene. In embodiments, the transgenic mouse or mouse cell has the genotype HLA-A2+HLA-DR1+β2m°IAβ°. The invention also relates to methods of using a transgenic mouse of the invention.
Public/Granted literature
Information query